Dr. Raymund Wellinger Becomes Action Researcher at CdRV

"I'm interested in everything, especially those things others find insignificant." On his laboratory website, Prof. Raymund Wellinger summarizes one of his defining personality features - a very curious mind.

Dr. Raymund Wellinger, who has recently been welcomed as an action researcher at the Research Centre on Aging (CdRV) and who is also the Canada Research Chair in Telomere Biology, is interested in the duplication stages of genetic material. His particular focus is on the ends of chromosomes, called "telomeres", which are essential for human genome stability.

The results of these studies will help to gain a better understanding of phenomena which enable human cancer cells to remain quasi immortal, compared to other cells in the body which appear to have a predetermined lifespan. These results will contribute to new cancer therapies and will improve our understanding of the molecular mechanisms of cell death (senescence).

An incredibly illustrious career

Of Swiss origin, Dr. Raymund Wellinger is a full professor at the department of microbiology and infectiology of the faculty of medicine and health sciences at the Université de Sherbrooke. He earned a Ph.D. in molecular biology from the Swiss Institute for Experimental Cancer Research (ISREC), which is affiliated with the Université de Lausanne (Switzerland, 1986), and completed his postdoctoral studies at the Fred Hutchinson Cancer Research Center (Seattle, USA, 1993). He worked for many years as an active researcher at the CRCHUS.

Over the course of his career, he also co-founded and served as Vice-President for Research (VPR) for the biotechnology firm Telogene Inc. He is credited with numerous international collaborative initiatives, five patents, and numerous publications in prestigious scientific journals, notably Cell, Nature, and Science.
As a renowned international researcher, Dr. Wellinger regularly sits on prestigious peer review committees entrusted with assigning research grants, including those of the U.S. National Institutes of Health (NIH) and the Canadian Institutes of Health Research (CIHR). He has served on the board of the Fonds de Recherche en Santé du Québec. Dr. Wellinger also conducts peer reviews and serves as an advisor in the selection of articles submitted for publication with numerous, world-renowned scientific journals, among them Science, Cell, Nature, Genes and Development, Molecular and Cellular Biology, and Proceedings of the National Academy of Sciences (USA).

Reading: "L'art de trouver un monde à soi," a profile of the researcher published in Liaison (French only).

More news